Roca Therapeutics
Roca Therapeutics is a biotechnology company that designs small molecules addressing dedicated pathobiological mechanisms (M2 Macrophages driven immunosuppression and resistant angiogenesis) recently linked to indications such as Uveal Melanoma as well as Renal Cell Carcinoma and Head and Neck Squamous Cell Carcinoma.
Total raised
€0
€0
Funding rounds
1
Investors
5
distinct backers
Active since
2022-09
latest 2022-09
Funding by year
EUR raised per yearSignals
Medium confidenceRaise-next likelihood22
base rate 30% for Other
- ▼ Overdue vs cohort gap
- ▼ Low backer re-investment
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-09-26 | Other | — | BPI,Eurobiomed Grand Sud,PACA Cancéropôle,Southern Regional council,UCA | View deal → |
Related news
- Roca Therapeutics Closes Seed Fundingfinsmes.com · 2022-09
Similar companies
same sector or country- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Mistral AI€3.5BFrance · AI
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- ContentSquare€1.3BFrance · Software